뒤로
BioNexus Gene Lab Corp (BGLC) 수입
BGLC 주가 차트
BGLC 수입
BioNexus Gene Lab Corp
$2.59
-2.26%
$-0.06
종가: Mar 24, 16:00:00 GMT-4
$2.59
0%
$0
애프터마켓: Mar 24, 20:00:00 GMT-4
아직 데이터 없음Earnings FAQ
BGLC의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
BioNexus Gene Lab Corp BGLC의 지난 분기 매출 실적은 어땠나요?
BioNexus Gene Lab Corp의 매출 추정치는 얼마인가요?
BioNexus Gene Lab Corp의 수익 품질 점수는 얼마인가요?
BioNexus Gene Lab Corp는 언제 수익을 보고하나요?
BioNexus Gene Lab Corp의 예상 수익은 얼마인가요?
BioNexus Gene Lab Corp은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$2.65
시가
$2.59
일일 범위
$2.53 - $2.59
52주 범위
$1.92 - $15.6
거래량
904
평균 거래량
22.0K
배당수익률
--
EPS(TTM)
-1.28
시가총액
$6.1M
BGLC란 무엇인가요?
BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. The company is headquartered in Kuala Lumpur, Wilayah Persekutuan. The company went IPO on 2020-03-11. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.